LU76435A1 - - Google Patents

Info

Publication number
LU76435A1
LU76435A1 LU76435A LU76435A LU76435A1 LU 76435 A1 LU76435 A1 LU 76435A1 LU 76435 A LU76435 A LU 76435A LU 76435 A LU76435 A LU 76435A LU 76435 A1 LU76435 A1 LU 76435A1
Authority
LU
Luxembourg
Application number
LU76435A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU76435A1 publication Critical patent/LU76435A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU76435A 1975-12-22 1976-12-20 LU76435A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,922 US4054738A (en) 1975-12-22 1975-12-22 Sodium cefamandole crystalline forms

Publications (1)

Publication Number Publication Date
LU76435A1 true LU76435A1 (en:Method) 1977-06-10

Family

ID=24578600

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76435A LU76435A1 (en:Method) 1975-12-22 1976-12-20

Country Status (31)

Country Link
US (1) US4054738A (en:Method)
JP (2) JPS5282714A (en:Method)
AR (1) AR213300A1 (en:Method)
AT (2) AT348678B (en:Method)
AU (1) AU505924B2 (en:Method)
BE (1) BE849415A (en:Method)
CA (1) CA1080696A (en:Method)
CH (1) CH628348A5 (en:Method)
CS (1) CS195746B2 (en:Method)
DD (1) DD128727A5 (en:Method)
DE (1) DE2654647C2 (en:Method)
DK (1) DK153156C (en:Method)
FI (1) FI66008C (en:Method)
FR (3) FR2361898A1 (en:Method)
GB (1) GB1565854A (en:Method)
GR (1) GR65891B (en:Method)
HU (1) HU172474B (en:Method)
IL (3) IL50977A (en:Method)
LU (1) LU76435A1 (en:Method)
MX (1) MX3840E (en:Method)
NL (1) NL187483C (en:Method)
NO (1) NO148887C (en:Method)
NZ (1) NZ182694A (en:Method)
OA (1) OA05518A (en:Method)
PH (1) PH12191A (en:Method)
PL (1) PL102739B1 (en:Method)
PT (1) PT65955B (en:Method)
RO (3) RO75964A (en:Method)
SE (3) SE424730B (en:Method)
SU (3) SU637087A3 (en:Method)
ZA (1) ZA766957B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof
JPH0677413B2 (ja) * 1985-05-03 1994-09-28 株式会社フジクラ 高圧直流送電用電力ケーブル
JPS629495U (en:Method) * 1985-07-01 1987-01-21
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496171A (en) * 1969-02-17 1970-02-17 Lilly Co Eli Process for improving the physical and chemical properties of cephaloglycin
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
US3862186A (en) * 1972-12-15 1975-01-21 Bristol Myers Co Process for the production of cephalexin monohydrate
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions

Also Published As

Publication number Publication date
PH12191A (en) 1978-11-21
SE443564B (sv) 1986-03-03
DK575576A (da) 1977-06-23
DE2654647C2 (de) 1982-06-24
NO764222L (en:Method) 1977-06-23
FI763682A7 (en:Method) 1977-06-23
AU2001376A (en) 1978-06-01
FR2351985A1 (fr) 1977-12-16
JPS5282714A (en) 1977-07-11
NO148887B (no) 1983-09-26
RO75964A (ro) 1981-02-28
OA05518A (fr) 1981-04-30
CS195746B2 (en) 1980-02-29
AR213300A1 (es) 1979-01-15
GR65891B (en:Method) 1980-12-01
CH628348A5 (de) 1982-02-26
FR2351985B1 (en:Method) 1980-06-27
AT349148B (de) 1979-03-26
SE441096B (sv) 1985-09-09
DD128727A5 (de) 1977-12-07
FR2361898A1 (fr) 1978-03-17
SE7614401L (sv) 1977-06-23
SE424730B (sv) 1982-08-09
PT65955B (en) 1978-06-15
NL187483C (nl) 1991-10-16
SE8201702L (sv) 1982-03-17
IL50977A (en) 1980-02-29
DK153156C (da) 1989-02-20
NL7614233A (nl) 1977-06-24
RO69709A (ro) 1980-04-15
NO148887C (no) 1984-01-04
FI66008B (fi) 1984-04-30
FR2351984A1 (fr) 1977-12-16
RO75963A (ro) 1981-02-28
FR2361898B1 (en:Method) 1980-03-14
BE849415A (fr) 1977-06-15
SU671732A3 (ru) 1979-06-30
DE2654647A1 (de) 1977-06-30
DK153156B (da) 1988-06-20
SE8201701L (sv) 1982-03-17
ATA948976A (de) 1978-07-15
HU172474B (hu) 1978-09-28
MX3840E (es) 1981-08-11
IL57386A0 (en) 1979-09-30
AU505924B2 (en) 1979-12-06
SU1018585A3 (ru) 1983-05-15
CA1080696A (en) 1980-07-01
US4054738A (en) 1977-10-18
SU637087A3 (ru) 1978-12-05
PL102739B1 (pl) 1979-04-30
ZA766957B (en) 1978-06-28
NZ182694A (en) 1978-09-25
FI66008C (fi) 1984-08-10
IL50977A0 (en) 1977-01-31
PT65955A (en) 1977-01-01
JPS624393B2 (en:Method) 1987-01-30
JPS61351B2 (en:Method) 1986-01-08
ATA217578A (de) 1978-08-15
FR2351984B1 (en:Method) 1980-06-27
GB1565854A (en) 1980-04-23
IL57387A0 (en) 1979-09-30
NL187483B (nl) 1991-05-16
AT348678B (de) 1979-02-26
JPS6183189A (ja) 1986-04-26

Similar Documents

Publication Publication Date Title
FI763682A7 (en:Method)
JPS5283382U (en:Method)
CH602965A5 (en:Method)
CH605297A5 (en:Method)
BG21552A1 (en:Method)
BG21624A1 (en:Method)
BG21789A1 (en:Method)
BG22041A1 (en:Method)
BG22115A1 (en:Method)
BG23040A1 (en:Method)
CH154275A4 (en:Method)
CH589120A5 (en:Method)
CH589528A5 (en:Method)
CH590107A5 (en:Method)
CH590459A5 (en:Method)
CH590733A5 (en:Method)
CH591181A5 (en:Method)
CH593196A5 (en:Method)
CH594150A5 (en:Method)
CH595164A5 (en:Method)
CH596328A5 (en:Method)
CH596901A5 (en:Method)
CH597310A5 (en:Method)
CH597361A5 (en:Method)
CH597366A5 (en:Method)